Wilson’s Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States

Wilson’s Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States

The economic and health care use burdens of Wilson’s disease (WD) are unknown. In this study, we aimed to quantify this health care resource use and economic burden. We performed a retrospective case‐control analysis of individuals in the Truven Health MarketScan Commercial Claims database (2007‐201...

Full description

Bibliographic Details
Main Authors:	Vinod K. Rustgi, Kapil Gupta, Christopher Tait, Abhishek Bhurwal, Savan Kabaria, Carolyn Catalano, You Li, Carlos D. Minacapelli
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2022-02-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1812

Similar Items

Hepatic Encephalopathy: A Review
by: Savan Kabaria, et al.
Published: (2021-08-01)

Predictors of do-not-resuscitate order utilization in decompensated cirrhosis hospitalized patients: A nationwide inpatient cohort study
by: Savan Kabaria, et al.
Published: (2021-05-01)

The Role of Race, Sex, and Age in Circadian Disruption and Metabolic Disorders
by: Clark Zhang, et al.
Published: (2022-01-01)

Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery
by: Yue Sandra Yin, et al.
Published: (2022-11-01)

Circadian Rhythms, the Gut Microbiome, and Metabolic Disorders
by: Eric Zhao, et al.
Published: (2022-01-01)

Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real‐World Claims Analysis
by: Vinod K. Rustgi, et al.
Published: (2020-10-01)

Endoscopic Ultrasound-Guided Liver Biopsy in Clinical Practice
by: Avik Sarkar, et al.
Published: (2022-01-01)

Economic Burden of HIV in a Commercially Insured Population in the United States
by: Cindy Y. Chen, et al.
Published: (2023-01-01)

The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus
by: Ankoor Patel, et al.
Published: (2024-01-01)

A Review of the Systemic Manifestations of Hepatitis B Virus Infection, Hepatitis D Virus, Hepatocellular Carcinoma, and Emerging Therapies
by: Katerina Roma, et al.
Published: (2024-01-01)

Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
by: T. Joseph Mattingly, et al.
Published: (2019-03-01)

Predictors of caregiver burden in patients with neurologic Wilson disease
by: Peng Wu, et al.
Published: (2020-06-01)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
by: Pelin Ozluk, PhD, et al.
Published: (2022-12-01)

Treatment patterns and economic burden of bacterial vaginosis among commercially insured women in the USA
by: Eren Watkins, et al.
Published: (2023-12-01)

Cost Burden of Endothelial Keratoplasty in Fuchs Endothelial Dystrophy: Real-World Analysis of a Commercially Insured US Population (2014–2019)
by: Dhaliwal DK, et al.
Published: (2022-04-01)

Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
by: Cassie A. Ludwig, et al.
Published: (2023-06-01)

Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
by: Kaitlin Benedict, et al.
Published: (2020-11-01)

Cost of treatment in a US commercially insured, HIV-1-infected population.
by: Caitlyn T Solem, et al.
Published: (2014-01-01)

Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
by: Kiss S, et al.
Published: (2016-12-01)

Causes of death among commercially insured multiple sclerosis patients in the United States.
by: Douglas S Goodin, et al.
Published: (2014-01-01)

Presumed ocular histoplasmosis syndrome in a commercially insured population, United States.
by: Kaitlin Benedict, et al.
Published: (2020-01-01)

Trends in rotator cuff repair rates and comorbidity burden among commercially insured patients younger than the age of 65 years, United States 2007-2016
by: Elizabeth L. Yanik, PhD, ScM, et al.
Published: (2021-11-01)

The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States
by: Kunal Saxena, et al.
Published: (2023-04-01)

Alternative Insurance in place of Commercial Insurance :Applicated Jurisprudent Study on Insurance for Cars.
by: Abdullah Mohammad Al- Rohei
Published: (2008-04-01)

Costs of Severe Maternal Morbidity in U.S. Commercially Insured and Medicaid Populations: An Updated Analysis
by: Christopher M. Black, et al.
Published: (2021-09-01)

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009
by: Dalal AA, et al.
Published: (2011-10-01)

The Impact of Demographic Burden on Insurance Density
by: Elena Nebolsina
Published: (2020-12-01)

Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
by: Kaitlin Benedict, et al.
Published: (2020-03-01)

Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
by: Kaitlin Benedict, et al.
Published: (2020-06-01)

Enfermedad de Wilson Wilson´ disease
by: J. R. Foruny Olcina, et al.
Published: (2010-01-01)

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
by: Monica Kobayashi, et al.
Published: (2023-11-01)

The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
by: Stephanie J Estes, et al.
Published: (2020-11-01)

Long term cost outcomes among commercially insured patients undergoing bariatric surgical procedures
by: Sonali Shambhu, et al.
Published: (2024-02-01)

Commercial insurance on co-operative basis /
by: 403554 Afzalur Rahman

Tail Risk in Commercial Property Insurance
by: Enrico Biffis, et al.
Published: (2014-09-01)

Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States
by: Curtis Lesley H, et al.
Published: (2008-06-01)

Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States.
by: Catherine H Bozio, et al.
Published: (2020-01-01)

Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States
by: Tzy-Chyi Yu, et al.
Published: (2019-02-01)

Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003–2021
by: Harsh Wadhwa, et al.
Published: (2023-10-01)

Wilson France: a national database for Wilson’s disease
by: Trocello Jean-Marc
Published: (2010-10-01)